Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | oxytocin receptor | Starlite/ChEMBL | References |
Homo sapiens | arginine vasopressin receptor 2 | Starlite/ChEMBL | References |
Homo sapiens | arginine vasopressin receptor 1B | Starlite/ChEMBL | References |
Homo sapiens | arginine vasopressin receptor 1A | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | calmodulin | 0.0038 | 0.5 | 0.5 |
Trypanosoma brucei | calmodulin | 0.0038 | 0.5 | 0.5 |
Echinococcus multilocularis | CalModulin family member (cmd 1) | 0.0038 | 0.5 | 0.5 |
Schistosoma mansoni | calmodulin | 0.0038 | 0.5 | 0.5 |
Echinococcus multilocularis | calmodulin | 0.0038 | 0.5 | 0.5 |
Onchocerca volvulus | Calmodulin homolog | 0.0038 | 0.5 | 0.5 |
Echinococcus multilocularis | calmodulin | 0.0038 | 0.5 | 0.5 |
Echinococcus granulosus | calmodulin | 0.0038 | 0.5 | 0.5 |
Giardia lamblia | Calmodulin | 0.0038 | 0.5 | 0.5 |
Trypanosoma brucei | calmodulin | 0.0038 | 0.5 | 0.5 |
Echinococcus multilocularis | calmodulin | 0.0038 | 0.5 | 0.5 |
Trypanosoma cruzi | calmodulin | 0.0038 | 0.5 | 0.5 |
Plasmodium falciparum | calmodulin | 0.0038 | 0.5 | 0.5 |
Trypanosoma cruzi | calmodulin, putative | 0.0038 | 0.5 | 0.5 |
Echinococcus granulosus | calmodulin | 0.0038 | 0.5 | 0.5 |
Leishmania major | calmodulin, putative | 0.0038 | 0.5 | 0.5 |
Leishmania major | calmodulin, putative | 0.0038 | 0.5 | 0.5 |
Entamoeba histolytica | calmodulin, putative | 0.0038 | 0.5 | 0.5 |
Toxoplasma gondii | calmodulin, putative | 0.0038 | 0.5 | 0.5 |
Trypanosoma cruzi | calmodulin | 0.0038 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.5 | 0.5 |
Echinococcus granulosus | calmodulin | 0.0038 | 0.5 | 0.5 |
Echinococcus granulosus | CalModulin family member cmd 1 | 0.0038 | 0.5 | 0.5 |
Trypanosoma brucei | calmodulin | 0.0038 | 0.5 | 0.5 |
Echinococcus multilocularis | calmodulin | 0.0038 | 0.5 | 0.5 |
Trypanosoma cruzi | calmodulin, putative | 0.0038 | 0.5 | 0.5 |
Leishmania major | calmodulin, putative | 0.0038 | 0.5 | 0.5 |
Plasmodium vivax | calmodulin, putative | 0.0038 | 0.5 | 0.5 |
Trichomonas vaginalis | calmodulin, putative | 0.0038 | 0.5 | 0.5 |
Trypanosoma cruzi | calmodulin, putative | 0.0038 | 0.5 | 0.5 |
Trypanosoma brucei | calmodulin | 0.0038 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 0.05 nM | Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay | ChEMBL. | 24874785 |
EC50 (binding) | = 4.2 nM | Agonist activity at human vasopressin V2 expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay | ChEMBL. | 24874785 |
EC50 (binding) | = 700 nM | Agonist activity at human vasopressin V1b expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay | ChEMBL. | 24874785 |
EC50 (binding) | > 10000 nM | Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay | ChEMBL. | 24874785 |
IC50 (binding) | > 10000 nM | Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay | ChEMBL. | 24874785 |
Inhibition (binding) | Antagonist activity at human vasopressin V1b expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay | ChEMBL. | 24874785 | |
Inhibition (binding) | Antagonist activity at human vasopressin V2 expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay | ChEMBL. | 24874785 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.